Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer

Experienced commercial leader to shape launch strategy and global market readiness for telitacicept and future pipeline opportunitiesCAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Dallan Murray as Chief Commercial Officer, effective immediately. “We’re thrilled to welcome Dallan to Vor Bio at this important inflection point,” said Jean-Paul Kress, M.D., Chi ...